يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"CI Edvard Smith"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
    دورية أكاديمية

    المؤلفون: Bost JP; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden. jeremy.bost@ki.se., Ojansivu M; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden., Munson MJ; Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceutical R&D, AstraZeneca, Mölndal, 43150, Sweden., Wesén E; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 41296, Sweden., Gallud A; Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceutical R&D, AstraZeneca, Mölndal, 43150, Sweden.; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 41296, Sweden., Gupta D; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Gustafsson O; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Saher O; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden.; Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, 11562, Egypt., Rädler J; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Higgins SG; Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London, London, SW7 2AZ, United Kingdom., Lehto T; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden.; Institute of Technology, University of Tartu, Nooruse 1, Tartu, 50411, Estonia., Holme MN; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden., Dahlén A; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Engkvist O; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Strömstedt PE; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Andersson S; Discovery Sciences, R&D, AstraZeneca, Gothenburg, 43150, Sweden., Edvard Smith CI; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden., Stevens MM; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden.; Department of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London, London, SW7 2AZ, United Kingdom., Esbjörner EK; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 41296, Sweden., Collén A; Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceutical R&D, AstraZeneca, Mölndal, 43150, Sweden.; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, 43150, Sweden., El Andaloussi S; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14157, Sweden. samir.el-andaloussi@ki.se.

    المصدر: Communications biology [Commun Biol] 2022 Mar 01; Vol. 5 (1), pp. 185. Date of Electronic Publication: 2022 Mar 01.

    نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE